期刊文献+

Inhibition of betulinic acid to growth and angiogenesis of human colorectal cancer cell in nude mice 被引量:1

白桦脂酸对人类大肠癌细胞裸鼠体内生长及血管生成的抑制作用(英文)
下载PDF
导出
摘要 Objective: Angiogenesis plays a major role in the pathogenesis of many disorders. Vascular endothelial growth factor (VEGF) has been shown to be the key regulator of normal and pathological angiogenesis. Many studies showed that decreased expression of VEGF has been inhibited growth and migration of cancer cells. The aim of this study was to explore the effects of Betulinic acid on the VEGF expression and the growth of colorectal cell SW480 xenografts in nude mice. Methods: The xenografts derived from colorectal cell SW480 were established in BALB/C nude mice. Inoculated mice were randomly divided into negative control (corn oil), low dose betulinic acid group (20 mg/kg/d) and high dose group (40 mg/kg/d). After 22 days, the animals were sacrificed; tumor volume and weights were measured. The mRNA level of VEGF was analyzed by quantitative real-time polymerase chain reaction. The expression of VEGF protein was detected by immunohistochemistry. Results: The tumor weight was significantly lower in low and high dose groups than in corn oil group (1.12 + 0.04, 0.43 + 0.02 vs 2.08 + 0.07; P 〈 0.05). The mRNA levels of VEGF was also significantly lower in betulinic acid treated groups (0.72 + 0.02, 0.38 + 0.01; P 〈 0.05) than in control group (1.08 + 0.04). H&E staining showed tumor tissue necrosis was observed in treatment groups. The positive expression of VEGF was lower in low and high dose groups than in corn eil group. Gray scale increased in low dose group and high dose group (121.1 + 2.8, 156.2 + 3.3, P 〈 0.05). Conclusion: Betulinic acid had significant inhibitory effect on VEGF expression and tumors growth of human colorectal cancer xenografts in vivo, and down-regulation of VEGF expression may account for one of the molecular mechanisms of the anticancer effects of betulinic acid.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2010年第3期153-157,共5页 中德临床肿瘤学杂志(英文版)
关键词 betulinic acid colorectal cancer vascular endothelial growth factor (VEGF) nude mice 血管生成 癌细胞 结肠 裸鼠 桦木
  • 相关文献

参考文献1

二级参考文献34

  • 1Yatabe Y, Mitsudomi T and Takahashi T. Maspin expression in normal lung and non-small cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation [J]. Oncogene 2004; 23: 4041-9.
  • 2Maass N, Hojo T, Zhang M, et al. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer [J]. Acta Oncol 2000; 39:931-4.
  • 3Zhang W, Shi HY, Zhang M. Maspin overpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins [J]. BMC Cancer 2005; 5: 50.
  • 4Liu J, Yin S, Reddy N, et al. Bax mediates the apoptosis-sensitizing effect of maspin [J]. Cancer Res 2004; 64: 1703-11.
  • 5Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells [J]. Cancer Biol Ther 2003; 2: 389-403.
  • 6Ngamkitidechakul C, Warejcka DJ, Burke JM, et al. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion maspin-like molecule [J]. J 31796-806. of ovalbumin to a Biol Chem 2003; 278:
  • 7Maass N, Hojo T, Rosel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis [J]. Clin Biochem 2001; 34: 303-7.
  • 8Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical feature [J]. Int J Cancer 2001; 95: 337-42.
  • 9Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers [J]. Clin Cancer Res 2001; 7: 812-7.
  • 10Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma [J]. Clin Cancer Res 2002; 8: 2924-32.

共引文献4

同被引文献9

  • 1MIKKO TAIPALE, DANIEL F. JAROSZ, SUSAN LINDQUIST. HSP90 at the hub of protein homeostasis: emerging mechanistic insights[J]. Nature Reviews Molecular Cell Biology, 2010, 11(2): 515-528.
  • 2LU XY, LI X, WANG L, et al. HSP90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs [J]. Biochemical Pharmacology, 2012, 83(8): 995-1004.
  • 3VIVIANE C.H. DA SILVA, CARLOS H.I. RAMOS. The network interaction of the human cytosolic 90 kDa heat shock protein HSP90: A target for cancer therapeutics[J]. Journal of Proteomies, 2012, 75(10): 2790-2802.
  • 4AUDESH BHAT, SUSANTHA GOMIS, ANDREW POTTER, et al. Role of HSP90 in CpG ODN mediated in avian macrophages[J]. Molecular Immunology, 2010: 1337-1346.
  • 5CHRISTINA B. CLARK, MADHAVI J. RANE, DELPHINE EL MEHDI, et al. Role of oxidative stress in geldanamycin-indueed eytotoxicity and disruption of HSP90 signaling complex[J]. Free Radical Biology and Medicine, 2009, 47(10): 1440-1449.
  • 6ANNIE MO, CRISTINA MUSSELLI, HONG CHEN, et al. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4 and CD8 cellular immunity and protective efficacy[J]. Vaccine, V2011, 29(47): 8530-8541.
  • 7MARl BUNKHOLT ELSTRAND, HELENE TUFT STAVNES, CLAES G. TROPIC, et al. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions[J]. Human Pathology, 2012, 43(4): 529-535.
  • 8JACEK R. WILCZYIqSKI. Thl/Th2 cytokines balance-yin and yang of reproductive immunology[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005, 122(2): 136-143.
  • 9MANJUNATHA ANKATHATTI MUNEGOWDA, SHULING XU, ANDREW FREYWALD, et al. CD4 Th2 cells function alike effector Trl and Thl cells through the deletion of a single cytokine IL-6 and IL-10 gene[J]. Molecular Immunology, 2012, 51(2): 143-149.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部